Building Fit-for-Purpose PRO Instruments: Focused Modern Measures Over General Instruments

Episode 1 February 10, 2026 00:20:13
Building Fit-for-Purpose PRO Instruments: Focused Modern Measures Over General Instruments
LifeSci Talks
Building Fit-for-Purpose PRO Instruments: Focused Modern Measures Over General Instruments

Feb 10 2026 | 00:20:13

/

Show Notes

In this episode of LifeSci Talks, Mark Wade, Global Practice Leader & COA SME at TransPerfect Life Sciences, is joined by Katja Rudell, VP of Patient-Centered Outcomes at Kielo Research, to take a behind-the-scenes look at the reality of patient-centered instrument development. They discuss diaries and quality of life tools, rare disease challenges, and proxy reporting, as well as the tradeoffs that can often occur in balancing regulatory rigor, patient burden, and realistic instrument usability. Listen in to hear why multiple instruments for the same disease can often create not only frustration for patients, but can also overburden them simultaneously. The episode will share suggestions as to how study teams can design smarter, more patient-centered measurement strategies.

Other Episodes

Episode 15

August 08, 2024 00:01:28
Episode Cover

From Interview to Endpoint: Understanding the Importance of Patient Listening to Build Better Outcomes

In this episode of TransPerfect LifeSci Talks, Mark Wade, Global Practice Leader at TransPerfect Life Sciences sits down with John Reites, Co-Founder and CEO...

Listen

Episode 8

November 28, 2023 00:25:24
Episode Cover

AI-Powered Innovations in Clinical Trials: Optimizing Every Step with Shae Wilkins

Explore how artificial intelligence is rapidly changing the landscape of clinical trials, from discovering new therapies and complex calculations to protocol optimization. Discover how...

Listen

Episode 3

May 05, 2026 00:27:48
Episode Cover

Are We Sacrificing Good for Perfect in Clinical Outcome Assessment?

In this episode of LifeSci Talks, Mark Wade, Global Practice Leader at TransPerfect Life Sciences, sits down with Stacie Hudgens, Chief Scientific and Strategy...

Listen